Roivant Sciences Limited

ROIV

Equity

ISIN BMG762791017 / Valor 113331044

NASDAQ (2026-04-24)

USD 27.41-2.59%

Roivant Sciences Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Roivant Sciences Limited is a biopharmaceutical company that focuses on developing and commercializing innovative therapies by leveraging technology to enhance drug development processes. The company aims to transform the pharmaceutical industry by integrating technology and data analytics into its operations, positioning itself as a pioneering PharmaTech entity. Roivant operates through a unique model of creating subsidiary companies, known as "Vants," each dedicated to specific therapeutic areas or technologies. This approach allows Roivant to efficiently manage and advance a diverse portfolio of drug candidates across various stages of development. The company is known for its strategic partnerships and collaborations, which help accelerate the development and commercialization of its therapies. Roivant's business strategy is centered on addressing unmet medical needs and improving patient outcomes through the application of cutting-edge technology and innovative drug development methodologies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

149%1Y

209%3Y

178%5Y

Performance

38.9%1Y

42.5%3Y

56.9%5Y

Volatility